Ocular Complications From Cancer Therapy - Patient Registry and Biobank

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 13, 2025

Primary Completion Date

April 30, 2031

Study Completion Date

April 30, 2031

Conditions
Graft Versus Host Disease in EyeOcular ComplicationsInflammatory Dry Eye Disease
Interventions
PROCEDURE

Eye exam

Previous medications, ocular history, medical history, clinical evaluations, surgical procedures and outcomes will be gathered on the patients who consent to participate. A standard of care exam will be performed to the reason for the visit. In addition to the standard of care exam, those in the Cancer Therapy arm will have certain biological samples (tear collection, impression cytology, and/or blood) collected, stored, and analyzed so we may obtain immunologic, cellular, or molecular mechanistic insights into disease pathogenesis.

Trial Locations (1)

21201

RECRUITING

Stoler Outpatient Cancer Center at the University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER